Saracatinib
- 1 lab in 1 country
- Funders: National Natural Science Foundation of China and 1 more
- Animals1
Outcomes
1Atherosclerosis
downin mice1
1 study
Atherosclerosis
downin mice1
Saracatinib protects against atherosclerosis in mice.
“saracatinib, a specific Src inhibitor, has been demonstrated to effectively alleviate diabetic atherosclerosis in experimental settings.”
Animalsin experimental settings
Advanced science (Weinheim, Baden-Wurttemberg, Germany)10 Jun 2025
Latest
Advanced Science
Lactate-Activated GPR132-Src Signal Induces Macrophage Senescence and Aggravates Atherosclerosis Under Diabetes
Experiments in miceCellular senescence